Finance & Investment

Riding a wave of record free cash flow and a bullish gold market, Kinross has announced a significant dividend increase, signaling confidence to investors.

Brown-Forman declared its quarterly dividend, continuing a 42-year streak of increases. What does this reveal about its financial strength and brand power?

TD Asset Management announced its latest ETF distributions, offering a glimpse into the changing landscape for income-focused Canadian investors.

Crown Capital posts a stunning Q4 profit, yet defaults on millions in debt payments, forcing a desperate race to sell assets to stave off collapse.

Sprott Physical Copper Trust plans monthly redemptions and a US market entry, aiming to boost liquidity as global demand for the critical metal soars.

After less than a year on the market, Westwood is closing its BFRE ETF. Here’s what investors need to know and what it says about the competitive ETF landscape.

Following a strategic balance sheet overhaul and strong earnings, the regional bank's new repurchase program sends a bullish message to investors.

Global X has terminated three ETFs, a strategic move that highlights key shifts in the booming Canadian ETF landscape. Here's what it means for investors.

Champion Homes unveils a stylish, attainable model at the Builders' Show, highlighting how offsite construction may be the answer to housing affordability.

After a year of major acquisitions and divestitures, the packaging giant posts surging profits and outlines a simplified, focused strategy for 2026.

Acurx Pharmaceuticals preps for pivotal Phase 3 trials for its novel C. diff antibiotic, Ibezapolstat, with global regulatory alignment in place.

Airwavz appoints a new CFO and creates a Chief Financial Strategist role, signaling a major push to dominate the booming in-building wireless market.

The veteran-founded coffee brand is on the clock after its stock price fell below $1.00, triggering a six-month window to brew a market turnaround.

With a new interim CEO and mounting financial pressure, VERSES AI's upcoming investor webinar is a pivotal test of its bio-inspired AI vision.

After a 1,000% stock surge on promising clinical data, Nektar Therapeutics secures $460M, fueling its next chapter in immunotherapy amid high hopes and risks.

Safe Bulkers sells a 14-year-old ship for $35.2M, capitalizing on a strong market to fund a new generation of eco-friendly vessels.

Rising repair costs and market volatility are forcing homeowners to rethink their selling strategy, seeking certainty over a potential bidding war.

Mark Hunt, the architect of SIM's rise to an $86B powerhouse, has stepped down, leaving questions about the future of the firm he built from the ground up.

Industry heavyweight Rick Seehausen takes the helm at Lenders One, a strategic move by Altisource to arm independent lenders for a shifting market.

A new ETF, EXEQ, uses AI to score and invest in corporate leadership, aiming to turn a qualitative trait into a data-driven source of returns.